BLOG/🇺🇸United States··daily

S&P 500 Technology Sector SEC Filings — April 02, 2026

USA S&P 500 Technology

12 high priority10 medium priority22 total filings analysed

Executive Summary

The 22 filings from USA S&P 500 Technology stream (April 2, 2026) are dominated by 10 proxy-related documents (DEF 14A/DEFA14A) for May 2026 AGMs, reflecting routine governance with neutral sentiment across NCS Multistage, Iridium, Radian Group, Apple Hospitality REIT, and Community Health Systems; no major disputes or declines noted. Executive transitions in 5 companies (Optimum Communications EVP demotion/retirement with $3.6M payout, Zoom COO resignation May 8, Broadcom CFO retirement Jun 12 with Alphabet CAO successor, Esquire director health-related exit, CareView ongoing debt amendments) are neutral, signaling stable leadership changes without disagreements. Positive financing and operational highlights include ISQ Open Infrastructure's $28.3M unregistered equity raise and $0.34/share distribution (May 5), Immunic's Phase 3 enrollment completion (2,221 patients, topline end-2026), CHS's 2025 net income turnaround to $509M from -$516M loss despite -1.2% YoY revenue to $12.5B, $3.3B debt reduction, and Aditxt Nasdaq compliance confirmation ($4M equity). Apple Hospitality reported 2025 buybacks of 5M shares, hotel portfolio optimization across 84 markets. Portfolio-level trends show sparse but improving financials (e.g., CHS EBITDA margin flat 12.2%, positive FCF), capital returns via buybacks/debt paydown/distributions, and catalysts like biotech data; implications favor monitoring leadership stability and May events amid low volatility.

Tracking the trend? Catch up on the prior S&P 500 Technology Sector SEC Filings digest from April 01, 2026.

Investment Signals(12)

  • 14th Credit Agreement amendment extends maturity to Jun 30, 2026, from prior 2015 deal; positive liquidity extension after 30+ mods

  • Issued unregistered shares raising $28.3M net proceeds Mar 2026, portfolio holdings increased, $0.34/share special distribution May 5, TNAV $32-34/share Feb end

  • Immunic(BULLISH)

    Phase 3 ENSURE enrollment complete (1,121/1,100 patients), positive Ph2 CALLIPER (PMS disability reduction) and Ph1b IMU-856 celiac data; $200M raised Feb 2026

  • 2025 net income $509M turnaround from 2024 -$516M loss, op cash flow +13.1% to $543M, $3.264B debt repurchased/redeemed despite rev -1.2% YoY

  • 2025 achievements include 2 hotel acquisitions, 7 sales, ~5M share buybacks, strong balance sheet/distributions across 84 markets

  • Unanimous EGM approval (3.4M FOR, 0 against) of SPAC reincorporation/merger with Bradbury Capital/Super Apps, minimal 1,153 shares redeemed (99.7% support)

  • Aditxt(BULLISH)

    Nasdaq confirms compliance with Rule 5550(b)(1) via $3.95M equity in Mar 31 10-K, resolves Dec 2025 deficiency

  • Broadcom(BULLISH)

    Appoints Amie Thuener (ex-Alphabet VP/CAO) CFO effective Jun 12, 2026 ($700k base, $1M sign-on, 50k RSU/PSU); outgoing CFO consulting to 2027

  • DEF 14A highlights 88% CEO/83% NEO at-risk 2025 comp (76%/72% performance equity), stock ownership guidelines 6x/2x base

  • Zoom Communications(NEUTRAL-BULLISH)

    COO Aparna Bawa resignation May 8 not due to disagreement, routine transition

  • Same-store rev +4.6% YoY, admissions/adjusted admissions up, expansions in 4 locations despite headline rev dip

  • Radian Group(NEUTRAL-BULLISH)

    Proxy seeks approval of 2026 Equity Plan, 11 directors, comp say-on-pay; forward risks noted but board FOR all

Risk Flags(10)

Opportunities(10)

Sector Themes(6)

  • Proxy Season Intensity

    10/22 filings (45%) are DEF/DEFA14A for May 20-22 AGMs (Iridium, Radian, Apple, etc.), routine director/auditor/comp votes with unanimous board FOR; low event risk, monitor say-on-pay

  • Executive Transitions Prevalent

    5/22 (23%) disclose churn (OPTU demotion, Zoom COO, Broadcom CFO, Esquire dir, CareView debt mods); all neutral/no disagreements, but avg materiality 7/10 signals watch for succession

  • Financing Resilience

    4 positives (CareView extension, ISQ $28M raise, Immunic $200M placement, Muzinich $5M NAV sale) vs historical debt loads; contrasts CHS rev dip, supports liquidity in volatile tech/health-tech

  • Capital Allocation Favoring Returns

    Buybacks (Apple 5M shares), distributions (ISQ $0.34/share), debt paydown (CHS $3.3B); REIT/fund focus (Apple, ISQ, MFS) prioritizes yields over growth reinvestment

  • Turnaround Metrics Outliers

    CHS net income +$1B swing YoY, positive FCF vs prior losses; Immunic enrollment complete amid biotech risks; 2/ few period comps show profitability inflection despite rev pressures

  • Catalyst Buildup in Bio/Infra Tech

    Immunic Ph3 data end-2026 standout; ISQ NAV growth/portfolio adds; proxies flag equity plan expansions (Iridium, Radian) for talent retention

Watch List(8)

Filing Analyses(22)
Optimum Communications, Inc.8-Kneutralmateriality 7/10

02-04-2026

Optimum Communications, Inc. (OPTU) announced that Michael E. Olsen, Executive Vice President, General Counsel and Chief Corporate Responsibility Officer, will transition from his current role effective October 1, 2026 (or earlier upon successor appointment) to Senior Executive Counsel, Capital Transformation through December 31, 2027, after which he will retire. Under the Transition, Retention and Retirement Agreement dated April 1, 2026, Mr. Olsen will receive a $3,575,000 lump-sum cash retention payment, fully earned on December 31, 2027, subject to continued employment, with no repayment required in qualifying terminations (e.g., without cause, good reason, death, or disability). Through the Transition Date, he continues current base salary and incentive eligibility; post-transition, base salary, benefits, and vesting continue but no new incentives.

  • ·In qualifying termination prior to December 31, 2027, entitled to lump sum base salary through that date and continued vesting of long-term incentive awards, subject to separation agreement and covenants.
  • ·Transition Agreement provides continued indemnification, D&O insurance coverage, and customary confidentiality, non-disparagement, and restrictive covenants.
  • ·Full Transition Agreement to be filed with Quarterly Report on Form 10-Q.
CareView Communications Inc8-Kpositivemateriality 7/10

02-04-2026

CareView Communications, Inc., along with its subsidiary Borrower, PDL Investment Holdings, LLC as Lender, Steven G. Johnson (President and CEO), and Dr. James R. Higgins (director), entered into the Fourteenth Amendment to the Credit Agreement on March 30, 2026, extending the Maturity Date to June 30, 2026. This amendment continues a long series of prior modifications to the original June 26, 2015 Credit Agreement and related Modification Agreement, with dozens of amendments listed dating back to 2015. The update creates or modifies a direct financial obligation under Item 2.03.

  • ·Original Credit Agreement dated June 26, 2015
  • ·Filing incorporates 30+ prior amendments to Credit Agreement and Modification Agreement as exhibits, with latest prior ones in December 2025
NCS Multistage Holdings, Inc.DEFA14Aneutralmateriality 3/10

02-04-2026

NCS Multistage Holdings, Inc. filed a DEFA14A Definitive Additional Proxy Material on April 02, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the Registrant with no fee required. No substantive proxy details or financial data are provided in the filing header.

  • ·Filing Type: SCHEDULE 14A (Amendment No. blank)
  • ·Check box: Definitive Additional Materials
  • ·Payment of Filing Fee: No fee required
NCS Multistage Holdings, Inc.DEF 14Aneutralmateriality 5/10

02-04-2026

NCS Multistage Holdings, Inc. filed a DEF 14A Proxy Statement for its 2026 Annual Meeting on May 27, 2026, seeking stockholder approval to elect John Deane and W. Matt Ralls as Class III directors until the 2029 Annual Meeting, ratify Grant Thornton LLP as independent auditors for the year ending December 31, 2026, and approve named executive officer compensation on an advisory basis. As of the March 30, 2026 Record Date, approximately 2,624,523 shares of Common Stock are outstanding and entitled to vote. The Board unanimously recommends voting FOR all proposals; no other matters are anticipated.

  • ·Board divided into three classes with staggered three-year terms: Class III (expiring 2026), Class I (expiring 2027), Class II (expiring 2028).
  • ·Advent International Corporation controls a majority of the voting power of Common Stock.
  • ·Annual Meeting location: 19350 State Highway 249, Suite 600, Houston, Texas 77070 at 8:00 a.m. Central Time.
  • ·Director election requires plurality of votes cast; broker non-votes and withheld votes have no effect.
Zoom Communications, Inc.8-Kneutralmateriality 7/10

02-04-2026

On March 30, 2026, Aparna Bawa notified Zoom Communications, Inc. of her resignation as Chief Operating Officer, effective May 8, 2026. The departure is not due to any disagreement with the company. The 8-K filing was submitted on April 2, 2026, and signed by Michelle Chang, Chief Financial Officer.

  • ·Company address: 55 Almaden Boulevard, 6th Floor, San Jose, California 95113
  • ·Class A Common Stock ($0.001 par value) traded on Nasdaq Global Select Market under symbol ZM
Iridium Communications Inc.DEFA14Aneutralmateriality 6/10

02-04-2026

Iridium Communications Inc. issued a DEFA14A notice for its 2026 Annual Meeting on May 20, 2026, seeking shareholder approval on the election of 11 director nominees, an advisory vote on named executive officer compensation, ratification of KPMG LLP as independent auditors for the fiscal year ending December 31, 2026, and approval of the Amended and Restated 2015 Equity Incentive Plan. The board recommends voting 'For' all proposals. Proxy materials, including the Proxy Statement and Form 10-K, are available online at www.ProxyVote.com or by request before May 6, 2026.

  • ·Annual Meeting: May 20, 2026 at 8:30 a.m. Eastern Time, virtually at www.virtualshareholdermeeting.com/IRDM2026
  • ·Voting deadline: May 19, 2026 11:59 PM ET
  • ·Material request deadline: May 6, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
Iridium Communications Inc.DEF 14Aneutralmateriality 6/10

02-04-2026

Iridium Communications Inc. will hold its 2026 Annual Meeting of Stockholders virtually on May 20, 2026 at 8:30 a.m. ET, with stockholders of record as of March 23, 2026 entitled to vote on electing 11 director nominees, an advisory vote to approve named executive officer compensation, ratification of KPMG LLP as independent auditor for fiscal year ending December 31, 2026, and approval of the Amended and Restated 2015 Equity Incentive Plan. The proxy statement highlights the executive compensation program where 88% of the CEO's 2025 target direct compensation and an average of 83% for other NEOs was at-risk, with 76% of CEO and 72% of NEO long-term equity incentives split evenly between service-based and performance-based RSUs. No declines or flat metrics are noted in the provided governance and compensation disclosures.

  • ·Annual Meeting location: www.virtualshareholdermeeting.com/IRDM2026
  • ·Proxy materials availability: on or about April 2, 2026 via www.proxyvote.com
  • ·Stock ownership guidelines: CEO 6x base salary, other executives 2x base salary
  • ·Prohibition on hedging and pledging Iridium shares by employees, executives, directors, and consultants
ISQ Open Infrastructure Co LLC8-Kpositivemateriality 8/10

02-04-2026

ISQ Open Infrastructure Co LLC issued and sold unregistered shares across multiple classes on March 1, 2026, raising total aggregate net proceeds of $28,284,860 from accredited and non-U.S. investors. During March 2026, the Company increased its holdings in existing portfolio companies and determined Transactional Net Asset Values per share ranging from $32.03 to $33.75 as of February 28, 2026, with total TNAV of $46,913 thousand for Series I and $207,006 thousand for Series II. It also declared a special cash distribution of $0.3399 per share across listed classes, payable on or about May 5, 2026.

  • ·GAAP Net Asset Value for Series I: $45,871 thousand as of February 28, 2026
  • ·GAAP Net Asset Value for Series II: $202,642 thousand as of February 28, 2026
  • ·Transactional NAV per share examples: F-STE Shares $32.20, F-J Shares $32.21, E Shares $33.75 as of February 28, 2026
  • ·Share sales exempt under Section 4(a)(2), Regulation D, and/or Regulation S
  • ·Distributions payable to holders of record March 31, 2026, on or about May 5, 2026, with option for reinvestment
RADIAN GROUP INCDEFA14Aneutralmateriality 8/10

02-04-2026

Radian Group Inc. issued a Definitive Additional Proxy Statement (DEFA14A) notice for its Annual Stockholder Meeting on May 21, 2026, at 9:00 a.m. EDT, held virtually via https://meetnow.global/MKZWLC7. Shareholders will vote on electing 11 director nominees (Board recommends FOR all), an advisory vote to approve named executive officer compensation (FOR), approval of the Radian Group Inc. 2026 Equity Compensation Plan (FOR), and ratification of PricewaterhouseCoopers LLP as independent auditors for the year ending December 31, 2026 (FOR). Proxy materials are available online at www.radian.com/stockholderreports or www.investorvote.com/RDN, with paper copy requests due by May 11, 2026.

  • ·Virtual meeting access: https://meetnow.global/MKZWLC7
  • ·Proxy materials request options: www.investorvote.com/RDN, phone 1-866-641-4276, or email investorvote@computershare.com
  • ·Board of Directors recommends FOR all four proposals
RADIAN GROUP INCDEF 14Aneutralmateriality 7/10

02-04-2026

Radian Group Inc. has issued its 2026 Proxy Statement for the virtual Annual Meeting of Stockholders on May 21, 2026, at 9:00 a.m. EDT, where shareholders will vote on electing eleven directors for one-year terms, an advisory approval of named executive officer compensation, approval of the 2026 Equity Compensation Plan, and ratification of PricewaterhouseCoopers LLP as independent auditors for the year ending December 31, 2026. The record date is March 23, 2026, and proxy materials are primarily provided via internet notice with paper copies available on request. Forward-looking statements highlight risks related to the acquisition of Inigo and plans to divest mortgage conduit, title, and real estate businesses.

  • ·Meeting access: https://meetnow.global/MKZWLC7
  • ·Proxy materials availability began on or about April 2, 2026
  • ·No physical location for the Annual Meeting
Apple Hospitality REIT, Inc.DEF 14Apositivemateriality 6/10

02-04-2026

Apple Hospitality REIT's 2026 definitive proxy statement announces the annual shareholder meeting on May 22, 2026, seeking approval for electing eight directors, ratifying KPMG LLP as independent auditors for 2026, and an advisory vote on executive compensation. The CEO letter highlights 2025 achievements including acquiring two hotels, selling seven hotels, repurchasing nearly five million common shares, and maintaining a strong balance sheet with attractive distributions across a portfolio spanning 84 markets in 37 states and DC. The company emphasizes strong governance, a refreshed board, employee stock purchase plan, and initiatives like Apple Gives, with no declines or flat performance noted.

  • ·Annual meeting location: Courtyard and Residence Inn, Richmond Downtown, 1320 East Cary Street, Richmond, Virginia 23219
  • ·Record date for shareholders: March 23, 2026
  • ·Proxy materials available at https://materials.proxyvote.com/03784Y
  • ·Notice of Internet Availability mailed or made available on or about April 2, 2026
Apple Hospitality REIT, Inc.DEFA14Aneutralmateriality 2/10

02-04-2026

Apple Hospitality REIT, Inc. filed Definitive Additional Proxy Materials (DEFA14A) on April 02, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing references the fiscal year period from January 1, 2023, to December 31, 2023, and no fee was required. No financial metrics, performance data, or other substantive details are included in the provided filing excerpt.

  • ·Filing marked as Definitive Additional Materials
  • ·No fee required for filing
COMMUNITY HEALTH SYSTEMS INCDEFA14Aneutralmateriality 3/10

02-04-2026

Community Health Systems, Inc. (CYH) filed Definitive Additional Materials (DEFA14A) on April 02, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is categorized as Definitive Additional Materials for proxy solicitation. No specific financial data, proposals, or substantive details are provided in the filing header.

IMMUNIC, INC.S-3positivemateriality 9/10

02-04-2026

Immunic, Inc., a late-stage biotechnology company with 92 employees developing oral therapies for MS and GI diseases, filed an S-3 registration statement on April 2, 2026, for the resale of up to 458,152,000 shares by selling stockholders from its February 2026 private placement raising approximately $200 million in gross proceeds. Positive developments include completion of enrollment in Phase 3 ENSURE trials (1,121 patients in ENSURE-1 and 1,100 in ENSURE-2) for vidofludimus calcium (IMU-838) in RMS with topline data expected by end of 2026, and positive Phase 2 CALLIPER results in PMS showing disability progression reductions. The company notes typical biotech risks such as clinical trial delays and funding needs.

  • ·February 2026 private placement: Pre-Funded Warrants exercisable at $0.0001/share; Common Warrants at $0.873220/share until Feb 17, 2031 or tied to ENSURE topline data.
  • ·Special stockholder meeting on April 14, 2026, for Reverse Stock Split approval (1-for-10 to 1-for-30 ratio, not exceeding 1-for-20).
  • ·Positive Phase 1b data for IMU-856 in celiac disease: gut protection, symptom improvement, biomarker response, nutrient absorption.
COMMUNITY HEALTH SYSTEMS INCDEF 14Amixedmateriality 8/10

02-04-2026

Community Health Systems' 2026 proxy statement summarizes 2025 performance, with net operating revenues declining 1.2% YoY to $12.485 billion despite 4.6% same-store revenue growth, and Adjusted EBITDA down 0.9% to $1.526 billion with a flat 12.2% margin. However, the company achieved a significant turnaround to net income of $509 million from a $516 million loss in 2024, alongside 13.1% higher cash flows from operations at $543 million. Debt reduction efforts included repurchasing or redeeming approximately $3.264 billion in notes through tenders, issuances, and redemptions throughout 2025.

  • ·Same-store admissions and adjusted admissions increased over 2024.
  • ·Acquired ambulatory surgery center in Laredo, Texas; expansions in Birmingham, AL; Statesboro, GA; Lufkin, TX; new urgent care in Las Cruces, NM.
  • ·Achieved positive free cash flows in 2025.
  • ·Stock price at Dec 31, 2025: $3.12 (up 4.3% from $2.99).
Planet Green Holdings Corp.S-3/Aneutralmateriality 6/10

02-04-2026

Planet Green Holdings Corp. filed Amendment No. 1 to its Form S-3 shelf registration statement on April 2, 2026, to register securities for potential future offerings, incorporating its 10-K for FY ended December 31, 2025, and recent 8-Ks. The company, a diversified holding entity in tea products, chemicals, and online advertising, disclosed recent divestitures of underperforming subsidiaries including Allinyson (April 2024), Jilin Chuangyuan via VIE termination (December 2024), and Shandong Yunchu/Promising Prospect HK (2025), alongside restructuring such as equity transfers in January 2026. It highlighted PRC regulatory risks on foreign exchange and cash transfers, with no dividends paid to date.

  • ·Discontinued Allinyson operations and divested 100% equity on April 1, 2024, due to recurring losses.
  • ·Terminated VIE agreements with Jilin Chuangyuan on December 11, 2024, ceasing financial consolidation due to underperformance.
  • ·Disposed of 100% equity in Promising Prospect HK for nominal consideration on September 1, 2025, removing Shandong Yunchu and Jiayi Technologies as subsidiaries.
  • ·On January 20, 2026, Hubei Bulaisi transferred 100% equity of Xianning Bozhuang to Dingfeng Technology; Xianning Bozhuang acquired 67% of Hubei Shengsili.
  • ·No dividends or distributions declared or paid to Planet Green from subsidiaries to date.
MFS HIGH INCOME MUNICIPAL TRUST425neutralmateriality 8/10

02-04-2026

MFS announced the adjournment of special shareholder meetings for MFS High Income Municipal Trust (CXE) and MFS Investment Grade Municipal Trust (CXH) to April 7, 2026, to solicit additional votes for their reorganizations into MFS Municipal Income Trust (MFM). The boards of the Target Funds approved the Reorganizations on December 10, 2025, and recommend approval, while MFM's board approved a new investment adviser (Aberdeen), five new trustees, and additional share issuance, all ratified by MFM shareholders on April 2, 2026. A conditional tender offer for up to 50% of CXH shares at 99% of NAV is contingent on Reorganization approval.

  • ·Target Fund boards unanimously approved Reorganizations on December 10, 2025.
  • ·Prospectus/proxy statements mailed to Target Fund shareholders as of December 11, 2025, in early February 2026.
  • ·CXH tender offer announced March 4, 2026; commencement contingent on Reorganization vote at adjourned meeting.
  • ·MFM proxy statement mailed to shareholders as of December 11, 2025, in early February 2026.
Broadcom Inc.8-Kneutralmateriality 8/10

02-04-2026

Broadcom Inc. announced that CFO Kirsten M. Spears will retire effective June 12, 2026, and the Board appointed Amie Thuener, previously Vice President, Corporate Controller and Chief Accounting Officer at Alphabet Inc., as successor CFO effective the same date, with her employment starting May 4, 2026. Ms. Spears will provide consulting services until March 15, 2027, with her equity awards continuing to vest. Ms. Thuener's compensation includes a $700,000 annual base salary, $1,000,000 sign-on bonus, 50,000 RSUs, and 50,000 PSUs at target.

  • ·Amie Thuener's employment commences May 4, 2026; equity awards expected June 15, 2026.
  • ·PSUs vest based on Broadcom's total stockholder return vs. S&P 500 and absolute TSR over four performance periods ending March 1, 2027-2030, with max vesting at 200% of target.
  • ·No family relationships or material interests for Ms. Thuener per Reg S-K Items 401(d) and 404(a).
Technology & Telecommunication Acquisition Corp8-Kpositivemateriality 10/10

02-04-2026

On March 30, 2026, Technology & Telecommunication Acquisition Corporation held an Extraordinary General Meeting where shareholders unanimously approved (3,407,509 FOR, 0 AGAINST/ABSTAIN) seven proposals, including the Reincorporation Merger into TETE TECHNOLOGIES INC (to be renamed Bradbury Capital Inc.), the Business Combination with Bradbury Capital Holdings Inc. and Super Apps Holdings Sdn. Bhd., Nasdaq share issuance, equity incentive plan, and election of new directors. 99.68% of entitled shares (3,418,316 total) were represented, with only 1,153 shares redeemed, indicating strong shareholder support. No negative votes were recorded across all proposals.

  • ·Business Combination Agreement originally dated August 2, 2023, as amended.
  • ·Meeting record date: February 25, 2026.
  • ·Securities traded on OTC Pink: Units (TETEF), Ordinary Shares (TETWF), Redeemable Warrants (TETUF).
Muzinich Corporate Lending Income Fund, Inc.8-Kneutralmateriality 6/10

02-04-2026

Muzinich Corporate Lending Income Fund, Inc. sold approximately $5,000,000 worth of its common stock, par value $0.001 per share, on April 1, 2026, with the sale price based on net asset value (NAV) per share as of March 31, 2026. The exact NAV per share and number of shares issued will be disclosed in an amendment to this Form 8-K within 20 business days. No underwriting discounts or commissions were paid, and the issuance is exempt from registration under Section 4(a)(2) and Rule 506(b) of Regulation D.

  • ·The Company did not engage in general solicitation or advertising with regard to the issuance and sale.
  • ·The Company is an emerging growth company.
  • ·Former name: Muzinich Direct Lending Income Fund, Inc. (changed July 13, 2023).
Esquire Financial Holdings, Inc.8-Kneutralmateriality 5/10

02-04-2026

Selig Zises resigned from all director and committee positions at Esquire Financial Holdings, Inc., Esquire Bank, National Association, and their affiliates, effective immediately on March 31, 2026, after over 17 years of service. The resignation is due to personal health and related disability concerns. It is explicitly stated that the resignation does not result from any disagreement with the Company or the Bank.

  • ·Filing submitted on April 02, 2026 under Items 5.02 and 9.01
Aditxt, Inc.8-Kpositivemateriality 7/10

02-04-2026

Aditxt, Inc. received a letter from Nasdaq on April 1, 2026, confirming compliance with Listing Rule 5550(b)(1) based on stockholders’ equity of $3,953,682 as reported in its Form 10-K filed March 31, 2026. This resolves the prior non-compliance notice dated December 1, 2025, and the matter is now closed. No other financial metrics or performance changes were disclosed.

  • ·Nasdaq Listing Rule 5550(b)(1) compliance confirmed via 10-K filing on March 31, 2026
  • ·Original non-compliance notice dated December 1, 2025

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 22 filings

🇺🇸 More from United States

View all →
S&P 500 Technology Sector SEC Filings — April 02, 2026 | Gunpowder Blog